Atlas Trials

WHO Grade III Glioma

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch WHO Grade III Glioma

RecordFirmDate
Combination Therapy for the Treatment of Diffuse Midline Gliomas (NCT05009992)University of California, San Francisco2021-10-20
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931)M.D. Anderson Cancer Center2020-01-30
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors (NCT04479696)M.D. Anderson Cancer Center2019-06-05
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (NCT03749187)University of California, San Francisco2019-04-03
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma (NCT03389230)City of Hope Medical Center2018-08-14
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers (NCT04630379)Mayo Clinic2018-06-13
Mind-Body Intervention in Glioma Couples (NCT03244995)M.D. Anderson Cancer Center2017-08-06
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma (NCT03251027)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2017-07-17
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma (NCT04540107)Susan Chang2017-01-11
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma (NCT01817751)Virginia Commonwealth University2013-04-11

Track WHO Grade III Glioma automatically

Every clearance here is in the API, with alerts when new ones post.